Pharmaxis to Acquire Topigen Pharmaceuticals

TOPIGEN Pharmaceuticals Inc., a Canadian-based clinical-stage biopharmaceutical company focused on innovative respiratory therapeutics, announced Tuesday that it has signed an agreement to be acquired by Pharmaxis Ltd., a publicly-traded Australian specialty pharmaceutical company involved in the research, development and commercialization of therapeutic products for chronic respiratory and immune disorders.
RTTNews